As Principal Investigator for three grants in breast cancer lymphedema (LE) measurement, occurrence, and impact funded by the National Institutes of Health, Dr. Armer has conducted extensive work in the area of LE prevalence, signs and symptoms, anthropometric measurement, and self-management among breast cancer survivors; fatigue among persons with LE; and self-management of chronic illness. She was Principle Investigator (PI) on two consecutive R01s funded by the National Institute for Nursing Research which followed breast cancer survivors (N>300) prospectively (from 0 through 30 months, then 36 months through 84 months post-diagnosis) to assess limb volume changes and other post-treatment outcomes over time. Dr. Armer is currently the subcontract PI on an NCI-funded grant prospectively examining lower limb LE following gynecological cancer. She also leads the lymphedema research in three NCI-funded Alliance Cooperative Oncology Group trials now underway.
In 2009, Dr. Armer completed the NINR-funded Summer Genetics Institute where she focused her efforts on the refinement of the Genome Wide Association Study in secondary LE. In 2011, she completed Klose Training’s advanced lymphedema management course at the Foeldi Clinic in Germany.
Dr. Armer has published more than 125 articles in the refereed literature, the majority on lymphedema and cancer survivorship. She has a strong record of mentoring doctoral students, junior faculty, and clinical colleagues. Over the course of this program of research in lymphedema, she has mentored undergraduate and graduate students in nursing, pre-nursing, pre-medicine, biology, family studies, pre-dental, health sciences, social work, journalism, physical therapy, computer science, and engineering fields of study.